Please Wait.....
Report
Allergy Diagnostics Market By Test Type (In Vivo, In Vitro), By Product & Service (Consumables, Instruments, Services), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By End-user (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-09-01 I 390 Pages I Allied Market Research
The global allergy diagnostic market is envisioned to garner $16,714.2 million by 2031, growing from $4,965.4 million in 2021 at a CAGR of 13.2% from 2022 to 2031.
An allergy is referred to as a systemic sensitivity condition in medical terminology. To assess whether the patient's body is allergic to any known substances, a competent allergy expert will perform an allergy diagnostic test. The diagnosis of allergy is typically made with a diagnostic test or a biopsy.
The main risk factors for developing chronic respiratory disorders are occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergy illnesses is higher among urban residents than rural residents (as a result of vehicular pollution and industrial activities). Although this is a worldwide trend, its impacts are more severe in the metropolitan regions of low-income nations, where more than 80% of people live in locations where air quality levels exceed WHO (World Health Organization) safety guidelines. Given that air pollution from automobiles has been identified as one of the key risk factors contributing to allergic disorders, this is a significant signal for the market growth for allergy diagnostic. Asthma, allergic rhinitis, and other allergy illnesses are more common when there is air pollution, according to epidemiological and toxicological study. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high concentrations of ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Members of the allergy and immunology communities have conducted studies that demonstrate how pollutants enhance early and late allergic reactions.
On the other side, it is also anticipated that the rising price of allergy diagnostic equipment would restrain the market expansion over the projected time frame. The shortage of allergists, however, may provide further difficulties for the development of the allergy diagnostic industry in the near future.
The market for allergy diagnostic is predicted to have lucrative opportunities due to the growing adoption of mHealth apps. The use of mHealth for rhinitis diagnosis is currently restricted since there are so few mHealth tools for Allergic Rhinitis (AR) diagnosis that have been published in peer-reviewed publications. Recent developments in integrated biosensors, wireless connectivity, and power harvesting methods have given rise to a new generation of point-of-care gadgets.
Due to the global COVID outbreak, there was a little reduction in the market for allergy diagnostics. Given that affected patients are well-instructed about avoiding potential environmental triggers and treating acute events, also based on written action plans, diagnostic procedures were postponed in the majority of allergic diseases. However, once the pandemic was under control, the diagnostic processes resumed.
The key players profiled in this report include Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMERIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergy diagnostic market analysis from 2021 to 2031 to identify the prevailing allergy diagnostic market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the allergy diagnostic market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global allergy diagnostic market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Test Type
- In Vitro
- In Vivo
By Product Service
- Consumables
- Instruments
- Services
By Allergen
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other Allergens
By End-user
- Diagnostic Laboratories
- Hospital-based Laboratories
- Academic Research Institutes
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA
- Key Market Players
- Alerchek Inc.
- Danaher Corp
- Hitachi chemical Diagnostic Inc.
- HOB Biotech Group Co. Ltd.
- Hycor Biomedical Inc.
- Lincoln Diagnostics Inc.
- Omega Diagnostic Llc
- Siemens Healthcare Diagnostics, Inc.
- Stallergenes SA
- Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc.
- Danaher
- Omega Diagnostics Group PLC
- Eurofins Scientific
- bioMerieux SA
- HollisterStier Allergy
- Minaris Medical America, Inc.
- ACON Laboratories, Inc.
- Lincoln Diagnostics, Inc.
- Neogen Corporation
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Regulatory Guidelines
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 In Vivo
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 In Vitro
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE
5.1 Overview
5.1.1 Market size and forecast
5.2 Consumables
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Instruments
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Services
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN
6.1 Overview
6.1.1 Market size and forecast
6.2 Inhaled Allergens
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Food Allergens
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug Allergens
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Other Allergens
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Diagnostic Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Hospital-based Laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Academic Research Institutes
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Test Type
8.2.3 North America Market size and forecast, by Product & Service
8.2.4 North America Market size and forecast, by Allergen
8.2.5 North America Market size and forecast, by End-user
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Test Type
8.2.6.1.2 Market size and forecast, by Product & Service
8.2.6.1.3 Market size and forecast, by Allergen
8.2.6.1.4 Market size and forecast, by End-user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Test Type
8.2.6.2.2 Market size and forecast, by Product & Service
8.2.6.2.3 Market size and forecast, by Allergen
8.2.6.2.4 Market size and forecast, by End-user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Test Type
8.2.6.3.2 Market size and forecast, by Product & Service
8.2.6.3.3 Market size and forecast, by Allergen
8.2.6.3.4 Market size and forecast, by End-user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Test Type
8.3.3 Europe Market size and forecast, by Product & Service
8.3.4 Europe Market size and forecast, by Allergen
8.3.5 Europe Market size and forecast, by End-user
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Test Type
8.3.6.1.2 Market size and forecast, by Product & Service
8.3.6.1.3 Market size and forecast, by Allergen
8.3.6.1.4 Market size and forecast, by End-user
8.3.6.2 UK
8.3.6.2.1 Market size and forecast, by Test Type
8.3.6.2.2 Market size and forecast, by Product & Service
8.3.6.2.3 Market size and forecast, by Allergen
8.3.6.2.4 Market size and forecast, by End-user
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Test Type
8.3.6.3.2 Market size and forecast, by Product & Service
8.3.6.3.3 Market size and forecast, by Allergen
8.3.6.3.4 Market size and forecast, by End-user
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Test Type
8.3.6.4.2 Market size and forecast, by Product & Service
8.3.6.4.3 Market size and forecast, by Allergen
8.3.6.4.4 Market size and forecast, by End-user
8.3.6.5 Italy
8.3.6.5.1 Market size and forecast, by Test Type
8.3.6.5.2 Market size and forecast, by Product & Service
8.3.6.5.3 Market size and forecast, by Allergen
8.3.6.5.4 Market size and forecast, by End-user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Test Type
8.3.6.6.2 Market size and forecast, by Product & Service
8.3.6.6.3 Market size and forecast, by Allergen
8.3.6.6.4 Market size and forecast, by End-user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Test Type
8.4.3 Asia-Pacific Market size and forecast, by Product & Service
8.4.4 Asia-Pacific Market size and forecast, by Allergen
8.4.5 Asia-Pacific Market size and forecast, by End-user
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Test Type
8.4.6.1.2 Market size and forecast, by Product & Service
8.4.6.1.3 Market size and forecast, by Allergen
8.4.6.1.4 Market size and forecast, by End-user
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Test Type
8.4.6.2.2 Market size and forecast, by Product & Service
8.4.6.2.3 Market size and forecast, by Allergen
8.4.6.2.4 Market size and forecast, by End-user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Test Type
8.4.6.3.2 Market size and forecast, by Product & Service
8.4.6.3.3 Market size and forecast, by Allergen
8.4.6.3.4 Market size and forecast, by End-user
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Test Type
8.4.6.4.2 Market size and forecast, by Product & Service
8.4.6.4.3 Market size and forecast, by Allergen
8.4.6.4.4 Market size and forecast, by End-user
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Test Type
8.4.6.5.2 Market size and forecast, by Product & Service
8.4.6.5.3 Market size and forecast, by Allergen
8.4.6.5.4 Market size and forecast, by End-user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Test Type
8.4.6.6.2 Market size and forecast, by Product & Service
8.4.6.6.3 Market size and forecast, by Allergen
8.4.6.6.4 Market size and forecast, by End-user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Test Type
8.5.3 LAMEA Market size and forecast, by Product & Service
8.5.4 LAMEA Market size and forecast, by Allergen
8.5.5 LAMEA Market size and forecast, by End-user
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Test Type
8.5.6.1.2 Market size and forecast, by Product & Service
8.5.6.1.3 Market size and forecast, by Allergen
8.5.6.1.4 Market size and forecast, by End-user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Test Type
8.5.6.2.2 Market size and forecast, by Product & Service
8.5.6.2.3 Market size and forecast, by Allergen
8.5.6.2.4 Market size and forecast, by End-user
8.5.6.3 United Arab Emirates
8.5.6.3.1 Market size and forecast, by Test Type
8.5.6.3.2 Market size and forecast, by Product & Service
8.5.6.3.3 Market size and forecast, by Allergen
8.5.6.3.4 Market size and forecast, by End-user
8.5.6.4 South Africa
8.5.6.4.1 Market size and forecast, by Test Type
8.5.6.4.2 Market size and forecast, by Product & Service
8.5.6.4.3 Market size and forecast, by Allergen
8.5.6.4.4 Market size and forecast, by End-user
8.5.6.5 Rest of LAMEA
8.5.6.5.1 Market size and forecast, by Test Type
8.5.6.5.2 Market size and forecast, by Product & Service
8.5.6.5.3 Market size and forecast, by Allergen
8.5.6.5.4 Market size and forecast, by End-user
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Alerchek Inc.
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Danaher Corp
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Hitachi chemical Diagnostic Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HOB Biotech Group Co. Ltd.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Hycor Biomedical Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lincoln Diagnostics Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Omega Diagnostic Llc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Siemens Healthcare Diagnostics, Inc.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Stallergenes SA
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermo Fisher Scientific Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 Thermo Fisher Scientific Inc.
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Danaher
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Omega Diagnostics Group PLC
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Eurofins Scientific
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 bioMerieux SA
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 HollisterStier Allergy
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 Minaris Medical America, Inc.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
10.18 ACON Laboratories, Inc.
10.18.1 Company overview
10.18.2 Company snapshot
10.18.3 Operating business segments
10.18.4 Product portfolio
10.18.5 Business performance
10.18.6 Key strategic moves and developments
10.19 Lincoln Diagnostics, Inc.
10.19.1 Company overview
10.19.2 Company snapshot
10.19.3 Operating business segments
10.19.4 Product portfolio
10.19.5 Business performance
10.19.6 Key strategic moves and developments
10.20 Neogen Corporation
10.20.1 Company overview
10.20.2 Company snapshot
10.20.3 Operating business segments
10.20.4 Product portfolio
10.20.5 Business performance
10.20.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 2. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR IN VIVO, BY REGION, 2021-2031 ($MILLION)
TABLE 3. WORLD ALLERGY DIAGNOSTIC MARKET FOR IN VIVO, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR IN VITRO, BY REGION, 2021-2031 ($MILLION)
TABLE 5. WORLD ALLERGY DIAGNOSTIC MARKET FOR IN VITRO, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 7. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 8. WORLD ALLERGY DIAGNOSTIC MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. WORLD ALLERGY DIAGNOSTIC MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. WORLD ALLERGY DIAGNOSTIC MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 14. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR INHALED ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. WORLD ALLERGY DIAGNOSTIC MARKET FOR INHALED ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR FOOD ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. WORLD ALLERGY DIAGNOSTIC MARKET FOR FOOD ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR DRUG ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 19. WORLD ALLERGY DIAGNOSTIC MARKET FOR DRUG ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR OTHER ALLERGENS, BY REGION, 2021-2031 ($MILLION)
TABLE 21. WORLD ALLERGY DIAGNOSTIC MARKET FOR OTHER ALLERGENS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. GLOBAL WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 23. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. WORLD ALLERGY DIAGNOSTIC MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 26. WORLD ALLERGY DIAGNOSTIC MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 28. WORLD ALLERGY DIAGNOSTIC MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. WORLD ALLERGY DIAGNOSTIC MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 30. WORLD ALLERGY DIAGNOSTIC MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 38. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 39. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 40. U.S. WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 41. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 42. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 43. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 44. CANADA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 45. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 46. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 47. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 48. MEXICO WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 49. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 50. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 51. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 52. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 53. EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 55. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 56. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 57. GERMANY WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 58. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 59. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 60. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 61. UK WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 62. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 63. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 64. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 65. FRANCE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 66. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 67. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 68. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 69. SPAIN WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 70. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 71. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 72. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 73. ITALY WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 74. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 75. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 76. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 77. REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 78. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 79. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 80. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 81. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 82. ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 83. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 84. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 85. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 86. CHINA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 87. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 88. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 89. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 90. JAPAN WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 91. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 92. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 93. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 94. INDIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 95. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 96. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 97. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 98. SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 99. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 100. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 101. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 102. AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 103. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 105. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 106. REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 107. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 108. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 109. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 110. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 111. LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 112. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 113. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 114. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 115. BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 116. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 117. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 118. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 119. SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 120. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 121. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 122. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 123. UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 124. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 125. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 126. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 127. SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 128. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 129. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2021-2031 ($MILLION)
TABLE 130. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2021-2031 ($MILLION)
TABLE 131. REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 132.ALERCHEK INC.: COMPANY SNAPSHOT
TABLE 133.ALERCHEK INC.: OPERATING SEGMENTS
TABLE 134.ALERCHEK INC.: PRODUCT PORTFOLIO
TABLE 135.ALERCHEK INC.: NET SALES,
TABLE 136.ALERCHEK INC.: KEY STRATERGIES
TABLE 137.DANAHER CORP: COMPANY SNAPSHOT
TABLE 138.DANAHER CORP: OPERATING SEGMENTS
TABLE 139.DANAHER CORP: PRODUCT PORTFOLIO
TABLE 140.DANAHER CORP: NET SALES,
TABLE 141.DANAHER CORP: KEY STRATERGIES
TABLE 142.HITACHI CHEMICAL DIAGNOSTIC INC.: COMPANY SNAPSHOT
TABLE 143.HITACHI CHEMICAL DIAGNOSTIC INC.: OPERATING SEGMENTS
TABLE 144.HITACHI CHEMICAL DIAGNOSTIC INC.: PRODUCT PORTFOLIO
TABLE 145.HITACHI CHEMICAL DIAGNOSTIC INC.: NET SALES,
TABLE 146.HITACHI CHEMICAL DIAGNOSTIC INC.: KEY STRATERGIES
TABLE 147.HOB BIOTECH GROUP CO. LTD.: COMPANY SNAPSHOT
TABLE 148.HOB BIOTECH GROUP CO. LTD.: OPERATING SEGMENTS
TABLE 149.HOB BIOTECH GROUP CO. LTD.: PRODUCT PORTFOLIO
TABLE 150.HOB BIOTECH GROUP CO. LTD.: NET SALES,
TABLE 151.HOB BIOTECH GROUP CO. LTD.: KEY STRATERGIES
TABLE 152.HYCOR BIOMEDICAL INC.: COMPANY SNAPSHOT
TABLE 153.HYCOR BIOMEDICAL INC.: OPERATING SEGMENTS
TABLE 154.HYCOR BIOMEDICAL INC.: PRODUCT PORTFOLIO
TABLE 155.HYCOR BIOMEDICAL INC.: NET SALES,
TABLE 156.HYCOR BIOMEDICAL INC.: KEY STRATERGIES
TABLE 157.LINCOLN DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 158.LINCOLN DIAGNOSTICS INC.: OPERATING SEGMENTS
TABLE 159.LINCOLN DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 160.LINCOLN DIAGNOSTICS INC.: NET SALES,
TABLE 161.LINCOLN DIAGNOSTICS INC.: KEY STRATERGIES
TABLE 162.OMEGA DIAGNOSTIC LLC: COMPANY SNAPSHOT
TABLE 163.OMEGA DIAGNOSTIC LLC: OPERATING SEGMENTS
TABLE 164.OMEGA DIAGNOSTIC LLC: PRODUCT PORTFOLIO
TABLE 165.OMEGA DIAGNOSTIC LLC: NET SALES,
TABLE 166.OMEGA DIAGNOSTIC LLC: KEY STRATERGIES
TABLE 167.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: COMPANY SNAPSHOT
TABLE 168.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: OPERATING SEGMENTS
TABLE 169.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
TABLE 170.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: NET SALES,
TABLE 171.SIEMENS HEALTHCARE DIAGNOSTICS, INC.: KEY STRATERGIES
TABLE 172.STALLERGENES SA: COMPANY SNAPSHOT
TABLE 173.STALLERGENES SA: OPERATING SEGMENTS
TABLE 174.STALLERGENES SA: PRODUCT PORTFOLIO
TABLE 175.STALLERGENES SA: NET SALES,
TABLE 176.STALLERGENES SA: KEY STRATERGIES
TABLE 177.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 178.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 179.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 180.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 181.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 182.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 183.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 184.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 185.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 186.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 187.DANAHER: COMPANY SNAPSHOT
TABLE 188.DANAHER: OPERATING SEGMENTS
TABLE 189.DANAHER: PRODUCT PORTFOLIO
TABLE 190.DANAHER: NET SALES,
TABLE 191.DANAHER: KEY STRATERGIES
TABLE 192.OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT
TABLE 193.OMEGA DIAGNOSTICS GROUP PLC: OPERATING SEGMENTS
TABLE 194.OMEGA DIAGNOSTICS GROUP PLC: PRODUCT PORTFOLIO
TABLE 195.OMEGA DIAGNOSTICS GROUP PLC: NET SALES,
TABLE 196.OMEGA DIAGNOSTICS GROUP PLC: KEY STRATERGIES
TABLE 197.EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 198.EUROFINS SCIENTIFIC: OPERATING SEGMENTS
TABLE 199.EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 200.EUROFINS SCIENTIFIC: NET SALES,
TABLE 201.EUROFINS SCIENTIFIC: KEY STRATERGIES
TABLE 202.BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 203.BIOMERIEUX SA: OPERATING SEGMENTS
TABLE 204.BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 205.BIOMERIEUX SA: NET SALES,
TABLE 206.BIOMERIEUX SA: KEY STRATERGIES
TABLE 207.HOLLISTERSTIER ALLERGY: COMPANY SNAPSHOT
TABLE 208.HOLLISTERSTIER ALLERGY: OPERATING SEGMENTS
TABLE 209.HOLLISTERSTIER ALLERGY: PRODUCT PORTFOLIO
TABLE 210.HOLLISTERSTIER ALLERGY: NET SALES,
TABLE 211.HOLLISTERSTIER ALLERGY: KEY STRATERGIES
TABLE 212.MINARIS MEDICAL AMERICA, INC.: COMPANY SNAPSHOT
TABLE 213.MINARIS MEDICAL AMERICA, INC.: OPERATING SEGMENTS
TABLE 214.MINARIS MEDICAL AMERICA, INC.: PRODUCT PORTFOLIO
TABLE 215.MINARIS MEDICAL AMERICA, INC.: NET SALES,
TABLE 216.MINARIS MEDICAL AMERICA, INC.: KEY STRATERGIES
TABLE 217.ACON LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 218.ACON LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 219.ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 220.ACON LABORATORIES, INC.: NET SALES,
TABLE 221.ACON LABORATORIES, INC.: KEY STRATERGIES
TABLE 222.LINCOLN DIAGNOSTICS, INC.: COMPANY SNAPSHOT
TABLE 223.LINCOLN DIAGNOSTICS, INC.: OPERATING SEGMENTS
TABLE 224.LINCOLN DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
TABLE 225.LINCOLN DIAGNOSTICS, INC.: NET SALES,
TABLE 226.LINCOLN DIAGNOSTICS, INC.: KEY STRATERGIES
TABLE 227.NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 228.NEOGEN CORPORATION: OPERATING SEGMENTS
TABLE 229.NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 230.NEOGEN CORPORATION: NET SALES,
TABLE 231.NEOGEN CORPORATION: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.WORLD ALLERGY DIAGNOSTIC MARKET SEGMENTATION
FIGURE 2.WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031
FIGURE 3.WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.WORLD ALLERGY DIAGNOSTIC MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.VALUE CHAIN ANALYSIS
FIGURE 13.REGULATORY GUIDELINES
FIGURE 14.MARKET SHARE ANALYSIS
FIGURE 15.KEY REGULATION ANALYSIS
FIGURE 16.PATENT ANALYSIS BY COMPANY
FIGURE 17.PATENT ANALYSIS BY COUNTRY
FIGURE 18.WORLD ALLERGY DIAGNOSTIC MARKET,BY TEST TYPE,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF IN VIVO WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF IN VITRO WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 21.WORLD ALLERGY DIAGNOSTIC MARKET,BY PRODUCT & SERVICE,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF SERVICES WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 25.WORLD ALLERGY DIAGNOSTIC MARKET,BY ALLERGEN,2021(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF INHALED ALLERGENS WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF FOOD ALLERGENS WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF DRUG ALLERGENS WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF OTHER ALLERGENS WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 30.WORLD ALLERGY DIAGNOSTIC MARKET,BY END-USER,2021(%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF HOSPITAL-BASED LABORATORIES WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF ACADEMIC RESEARCH INSTITUTES WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 34.COMPARATIVE SHARE ANALYSIS OF OTHERS WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031(%)
FIGURE 35.WORLD ALLERGY DIAGNOSTIC MARKET BY REGION,2021
FIGURE 36.U.S. WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 37.CANADA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 38.MEXICO WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 39.GERMANY WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 40.UK WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 41.FRANCE WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 42.SPAIN WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 43.ITALY WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 44.REST OF EUROPE WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 45.CHINA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 46.JAPAN WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 47.INDIA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 48.SOUTH KOREA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 49.AUSTRALIA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 50.REST OF ASIA-PACIFIC WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 51.BRAZIL WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 52.SAUDI ARABIA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 53.UNITED ARAB EMIRATES WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 54.SOUTH AFRICA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 55.REST OF LAMEA WORLD ALLERGY DIAGNOSTIC MARKET,2021-2031($MILLION)
FIGURE 56. TOP WINNING STRATEGIES, BY YEAR
FIGURE 57. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 58. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 59.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 60.COMPETITIVE DASHBOARD
FIGURE 61.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 62.ALERCHEK INC..: NET SALES ,($MILLION)
FIGURE 63.DANAHER CORP.: NET SALES ,($MILLION)
FIGURE 64.HITACHI CHEMICAL DIAGNOSTIC INC..: NET SALES ,($MILLION)
FIGURE 65.HOB BIOTECH GROUP CO. LTD..: NET SALES ,($MILLION)
FIGURE 66.HYCOR BIOMEDICAL INC..: NET SALES ,($MILLION)
FIGURE 67.LINCOLN DIAGNOSTICS INC..: NET SALES ,($MILLION)
FIGURE 68.OMEGA DIAGNOSTIC LLC.: NET SALES ,($MILLION)
FIGURE 69.SIEMENS HEALTHCARE DIAGNOSTICS, INC..: NET SALES ,($MILLION)
FIGURE 70.STALLERGENES SA.: NET SALES ,($MILLION)
FIGURE 71.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
FIGURE 72.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
FIGURE 73.DANAHER.: NET SALES ,($MILLION)
FIGURE 74.OMEGA DIAGNOSTICS GROUP PLC.: NET SALES ,($MILLION)
FIGURE 75.EUROFINS SCIENTIFIC.: NET SALES ,($MILLION)
FIGURE 76.BIOMERIEUX SA.: NET SALES ,($MILLION)
FIGURE 77.HOLLISTERSTIER ALLERGY.: NET SALES ,($MILLION)
FIGURE 78.MINARIS MEDICAL AMERICA, INC..: NET SALES ,($MILLION)
FIGURE 79.ACON LABORATORIES, INC..: NET SALES ,($MILLION)
FIGURE 80.LINCOLN DIAGNOSTICS, INC..: NET SALES ,($MILLION)
FIGURE 81.NEOGEN CORPORATION.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security